1
|
Favaron A, Hens B, Camotti Montanha M, McAllister M, Tomaszewska I, Moustafa S, de Oliveira MA, Basit AW, Orlu M. Can in vitro/in silico tools improve colonic concentration estimations for oral extended-release formulations? A case study with upadacitinib. J Control Release 2024; 370:182-194. [PMID: 38641022 DOI: 10.1016/j.jconrel.2024.04.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2023] [Revised: 03/12/2024] [Accepted: 04/12/2024] [Indexed: 04/21/2024]
Abstract
Upadacitinib, classified as a highly soluble drug, is commercially marketed as RINVOQ®, a modified-release formulation incorporating hydroxypropyl methylcellulose as a matrix system to target extended release throughout the gastrointestinal (GI) tract. Our study aimed to explore how drug release will occur throughout the GI tract using a plethora of in vitro and in silico tools. We built a Physiologically-Based Pharmacokinetic (PBPK) model in GastroPlus™ to predict the systemic concentrations of the drug when administered using in vitro dissolution profiles as input to drive luminal dissolution. A series of in vitro dissolution experiments were gathered using the USP Apparatus I, III and IV in presence of biorelevant media, simulating both fasted and fed state conditions. A key outcome from the current study was to establish an in vitro-in vivo correlation (IVIVC) between (i) the dissolution profiles obtained from the USP I, III and IV methods and (ii) the fraction absorbed of drug as deconvoluted from the plasma concentration-time profile of the drug. When linking the fraction dissolved as measured in the USP IV model, a Level A IVIVC was established. Moreover, when using the different dissolution profiles as input for PBPK modeling, it was also observed that predictions for plasma Cmax and AUC were most accurate for USP IV compared to the other models (based on predicted versus observed ratios). Furthermore, the PBPK model has the utility to extract the predicted concentrations at the level of the colon which can be of utmost interest when working with specific in vitro assays.
Collapse
Affiliation(s)
- Alessia Favaron
- UCL School of Pharmacy, University College London, London WC1N 1AX, UK
| | - Bart Hens
- Drug Product Design, Pfizer, Sandwich, Kent CT13 9NJ, United Kingdom.
| | | | - Mark McAllister
- Drug Product Design, Pfizer, Sandwich, Kent CT13 9NJ, United Kingdom
| | - Irena Tomaszewska
- Drug Product Design, Pfizer, Sandwich, Kent CT13 9NJ, United Kingdom
| | - Shaimaa Moustafa
- Drug Product Design, Pfizer, Sandwich, Kent CT13 9NJ, United Kingdom
| | | | - Abdul W Basit
- UCL School of Pharmacy, University College London, London WC1N 1AX, UK..
| | - Mine Orlu
- UCL School of Pharmacy, University College London, London WC1N 1AX, UK..
| |
Collapse
|
2
|
Pezzini BR, Issa MG, Duque MD, Ferraz HG. Applications of USP apparatus 3 in assessing the in vitro release of solid oral dosage forms. BRAZ J PHARM SCI 2015. [DOI: 10.1590/s1984-82502015000200003] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
<p>USP Apparatus 3 (reciprocating cylinder) is a very versatile device for the <italic>in vitro</italic> assessment of release characteristics of solid oral dosage forms, because it enables the product to be subjected to different dissolution media and agitation speeds in a single run. In this paper, a brief history and a description of this system are presented, along with its applications in the development of immediate and modified release products and in the simulation of fasted and fed states using biorelevant media. Furthermore, a comparison is made with the basket and paddle apparatus, especially highlighting the superior hydrodynamics of USP apparatus 3, since the results are not sensitive to factors such as the presence of sample collection probes or air bubbles in the dissolution medium.</p>
Collapse
|
3
|
Ferrero C, Jiménez-Castellanos M. In vitro release testing of matrices based on starch–methyl methacrylate copolymers: Effect of tablet crushing force, dissolution medium pH and stirring rate. Int J Pharm 2014; 461:270-9. [DOI: 10.1016/j.ijpharm.2013.12.001] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2013] [Revised: 12/01/2013] [Accepted: 12/04/2013] [Indexed: 11/29/2022]
|
4
|
A Semi-mechanistic Modeling Strategy to Link In Vitro and In Vivo Drug Release for Modified Release Formulations. Pharm Res 2011; 29:695-706. [DOI: 10.1007/s11095-011-0594-3] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2011] [Accepted: 09/14/2011] [Indexed: 10/17/2022]
|
5
|
Shiko G, Gladden L, Sederman A, Connolly P, Butler J. MRI Studies of the Hydrodynamics in a USP 4 Dissolution Testing Cell. J Pharm Sci 2011; 100:976-91. [DOI: 10.1002/jps.22343] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2010] [Accepted: 08/16/2010] [Indexed: 11/07/2022]
|
6
|
Heigoldt U, Sommer F, Daniels R, Wagner KG. Predicting in vivo absorption behavior of oral modified release dosage forms containing pH-dependent poorly soluble drugs using a novel pH-adjusted biphasic in vitro dissolution test. Eur J Pharm Biopharm 2010; 76:105-11. [DOI: 10.1016/j.ejpb.2010.05.006] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2010] [Revised: 05/05/2010] [Accepted: 05/10/2010] [Indexed: 10/19/2022]
|
7
|
Parojcić J, Ethurić Z, Jovanović M, Ibrić S, Jovanović D. Influence of dissolution media composition on drug release and in-vitro/in-vivo correlation for paracetamol matrix tablets prepared with novel carbomer polymers. J Pharm Pharmacol 2010; 56:735-41. [PMID: 15231038 DOI: 10.1211/0022357023583] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
Abstract
Abstract
The influence of dissolution media composition on drug release kinetics and in-vitro/in-vivo correlation (IVIVC) for hydrophilic matrix tablets based on Carbopol 971P and Carbopol 71G was investigated. A number of buffered and unbuffered media differing with respect to their pH value, ionic strength and ionic species was evaluated. The observed in-vitro drug release profiles were compared with the hypothetical drug release profiles in-vivo calculated by numerical deconvolution from the results of an in-vivo study. The obtained IVIVC plots were examined using linear and non-linear (proportional odds, proportional hazards and proportional reversed hazards) mathematical models. Although the studied sustained release agents were chemically identical, they exhibited pronounced differences in drug product behaviour both in-vitro and in-vivo. The use of non-linear modelling resulted in an improved level of correlation, especially in the case of Carbopol 71G matrices. The obtained results indicated the susceptibility of drug release kinetics and hence IVIVC in the case of anionic polymer matrices to media composition, and emphasized the need for thorough evaluation of applied media during the development of biorelevant dissolution methodology. Although the use of non-linear modelling could be advantageous, the need for a simple and meaningful nonlinear relationship is pointed out.
Collapse
Affiliation(s)
- J Parojcić
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11221 Belgrade, Serbia and Montenegro.
| | | | | | | | | |
Collapse
|
8
|
Ramos Pezzini B, Gomes Ferraz H. Bio-dis and the paddle dissolution apparatuses applied to the release characterization of ketoprofen from hypromellose matrices. AAPS PharmSciTech 2009; 10:763-71. [PMID: 19495988 DOI: 10.1208/s12249-009-9262-x] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2008] [Accepted: 05/15/2009] [Indexed: 11/30/2022] Open
Abstract
The purposes of this work were: (1) to comparatively evaluate the effects of hypromellose viscosity grade and content on ketoprofen release from matrix tablets, using Bio-Dis and the paddle apparatuses, (2) to investigate the influence of the pH of the dissolution medium on drug release. Furthermore, since direct compression had not shown to be appropriate to obtain the matrices under study, it was also an objective (3) to evaluate the impact of granulation on drug release process. Six formulations of ketoprofen matrix tablets were obtained by compression, with or without previous granulation, varying the content and viscosity grade of hypromellose. Dissolution tests were carried out at a fixed pH, in each experiment, with the paddle method (pH 4.5, 6.0, 6.8, or 7.2), while a pH gradient was used in Bio-Dis (pH 1.2 to 7.2). The higher the hypromellose viscosity grade and content were, the lower the amount of ketoprofen released was in both apparatuses, the content effect being more expressive. Drug dissolution enhanced with the increase of the pH of the medium due to its pH-dependent solubility. Granulation caused an increase in drug dissolution and modified the mechanism of the release process.
Collapse
|
9
|
Yadav MR, Shaikh AR, Ganesan V, Giridhar R, Chadha R. Studies on the Crystal forms of Pefloxacin: Preparation, Characterization, and Dissolution Profile. J Pharm Sci 2008; 97:2637-48. [PMID: 17854073 DOI: 10.1002/jps.21178] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Different crystal forms of pefloxacin were prepared using solvents of varying polarity. X-ray diffractometry (XRD), differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), infrared absorption spectroscopy (FT-IR), melting point, microcalorimetry and in vitro dissolution rate studies were conducted to investigate various characterstics of different crystalline forms of the pefloxacin. Five different polymorphs of pefloxacin have been identified on the basis of instrumental techniques. The polymorphs differed in their dissolution profile and all of them showed unusual behavior of highest dissolution in the first 15 min. The rate of dissolution went on decreasing and got stabilized to a constant value after 4 h.
Collapse
Affiliation(s)
- Mange Ram Yadav
- Pharmacy Department, Faculty of Technology and Engineering, The M. S. University of Baroda, Baroda, Vadodara 390 001, India.
| | | | | | | | | |
Collapse
|
10
|
Ribeiro L, Ferreira DC, Veiga FJB. In vitro controlled release of vinpocetine-cyclodextrin-tartaric acid multicomponent complexes from HPMC swellable tablets. J Control Release 2004; 103:325-39. [PMID: 15763617 DOI: 10.1016/j.jconrel.2004.12.001] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2004] [Revised: 11/24/2004] [Accepted: 12/02/2004] [Indexed: 11/15/2022]
Abstract
The objective of this study was to investigate the effect of multicomponent complexation (MCC) of vinpocetine (VP), a poorly soluble base-type drug, with beta-cyclodextrin (betaCD), sulfobutylether beta-cyclodextrin (SBEbetaCD), tartaric acid (TA), polyvinylpyrrolidone (PVP) and hydroxypropylmethylcellulose (HPMC), on the design of controlled release hydrophilic HPMC tablets and to evaluate their in vitro release profiles by a pH gradient method. Multicomponent complexation led to enhanced dissolution properties of VP both in simulated gastric and intestinal fluids, and became possible the development of HPMC tablet formulations with more independent pH dissolution profiles. Drug release process was investigated experimentally using USP apparatus 3 and by means of model-independent parameters. Responses studied included similarity of dissolution profiles, time for 60% of the drug to dissolve (T(60%)), percent of VP released after 7 h (PD(7 h)) and the dissolution efficiency parameter at 12 h (DE(12 h)). Influence of multicomponent complexation was proved to increase the release of VP from HPMC tablets and superior PD(7 h) and DE(12 h) values were obtained in formulations containing VP-CD-TA complexes. Results supported the use of HPMC matrices to provide a useful tool in retarding the release of VP and that dissolution characteristics of the drug may be modulated by multicomponent complexation in these delivery systems, suggesting an improvement on VP bioavailability.
Collapse
Affiliation(s)
- Laura Ribeiro
- Laboratory of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, 3000-004 Coimbra, Portugal.
| | | | | |
Collapse
|
11
|
Furlanetto S, Maestrelli F, Orlandini S, Pinzauti S, Mura P. Optimization of dissolution test precision for a ketoprofen oral extended-release product. J Pharm Biomed Anal 2003; 32:159-65. [PMID: 12852458 DOI: 10.1016/s0731-7085(03)00032-3] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
An example of application of experimental design methodologies to the set up of dissolution test conditions for a new ketoprofen oral extended-release dosage form is presented. The aim of the work was to find the best experimental conditions, using a USP apparatus 2 (paddle), for maximizing the method precision as degree of repeatability. The considered factors mainly influencing the dissolution test results were pH and volume of dissolution medium, and paddle stirring speed. Two distinct 4-run Plackett-Burman designs were carried out: one at gastric and the other at intestinal pH values. Each run was performed in triplicate in order to calculate the standard deviations of the drug dissolution efficiency at 60 and 120 min, selected as responses to be minimized. Optimum conditions to carry out the dissolution test were: 900 ml volume of dissolution medium and 70 rpm paddle stirring speed for both environments and pH 1 and 5.5, for the gastric and intestinal environment, respectively.
Collapse
Affiliation(s)
- S Furlanetto
- Department of Pharmaceutical Sciences, University of Florence, Via G. Capponi 9, 50121 Florence, Italy
| | | | | | | | | |
Collapse
|
12
|
Raghavan SL, Ristic RI, Sheen DB, Sherwood JN. Dissolution kinetics of single crystals of alpha-lactose monohydrate. J Pharm Sci 2002; 91:2166-74. [PMID: 12226843 DOI: 10.1002/jps.10208] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
The dissolution kinetics of alpha-lactose monohydrate (alphaLM) single crystals were studied by a flow-cell method at different undersaturations. Linear dissolution profiles were obtained as a function of time for all the faces except the (010) face. The dissolution rates, obtained from these profiles, were anisotropic and varied considerably with undersaturation. At low undersaturations (0-2%), the order of dissolution rate was (110) > (100) > (011) = (110) > (010). This order changed with increasing undersaturation (>5%) to (011) >> (100) > (110) > (110) > (010). In alphaLM crystals in which lattice strain was induced by synchrotron X-irradiation, the rates of dissolution of all faces increased with increasing strain. The increase was less significant for the (011) faces than for the remainder. Under this constraint, the (010) face became the fastest dissolving one and the [011]face became the slowest one. The results of all experiments are explained on the basis that although dislocations may act as initiating dissolution centers at very low undersaturations, these sources rapidly give way to two-dimensional nucleation of randomly distributed dissolution sites as the undersaturation is increased. Under these conditions, which better reflect the normal dissolution processes of materials, bulk lattice strain plays the most significant role in defining the dissolution rate. The results show a potential route to the controlled engineering of the dissolution behavior of crystalline materials.
Collapse
Affiliation(s)
- S L Raghavan
- Department of Pure and Applied Chemistry, University of Strathclyde, Glasgow, G1 1XL, Scotland, United Kingdom
| | | | | | | |
Collapse
|